[Fatty acid synthase: a new anti-tumor target]

Related Experiment Video

Updated: Jun 25, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Teresa Puig1, Rut Porta, Ramon Colomer

  • 1Oncología Médica, Instituto Catalán de Oncología (ICO-Girona) Instituto de Investigación Biomédica de Girona (IdIBGi), Hospital Universitari Dr. Josep Trueta, Girona, España. mtpuig@iconcologia.net

Medicina Clinica
|March 10, 2009
PubMed

Insights

Fatty acid synthase (FASN) is highly active in many cancers, making it a target for new treatments. Inhibiting FASN shows promise for selectively killing cancer cells and improving cancer diagnostics and therapies.

Area of Science:

  • Biochemistry
  • Oncology
  • Metabolic pathways

Context:

  • Fatty acid synthase (FASN) is upregulated in numerous human carcinomas.
  • FASN activity is linked to poor prognosis in prostate and breast cancers.
  • Cancer cells exhibit selective sensitivity to FASN inhibition.

Purpose:

  • To highlight the significance of FASN in cancer biology.
  • To underscore the therapeutic potential of FASN inhibitors.
  • To emphasize the role of fatty acid metabolism in cancer diagnostics and treatment.

Summary:

  • Fatty acid synthase (FASN) catalyzes de novo fatty acid synthesis and is overexpressed in most human carcinomas.
  • FASN inhibition demonstrates selective cytotoxicity towards cancer cells, indicating its potential as a therapeutic target.
  • The enzyme's role in fatty acid metabolism positions it as a critical focus for cancer diagnosis and treatment strategies.

Impact:

  • Identifies FASN as a key player in cancer progression and a viable target for novel antitumor agents.
  • Suggests that targeting FASN could lead to improved diagnostic and therapeutic approaches for various cancers.
  • Stimulates further research into developing and validating FASN inhibitors for clinical application in oncology.

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Related Concept Videos

Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.